Canadian Strategic Planning & Agency Representation:

  PDi has experience with drugs in most major therapeutic areas. We can participate in regulatory, scientific and practical support for pre-clinical and clinical development, CMC, and post-approval positioning.
PDi will liaise directly or indirectly with regulatory agencies on your behalf in order to support your projects.
PDi offers proven experience in the Canadian Pharmaceutical Industry. We can provide recommendations during drug development that will help you satisfy the requirements of our regulatory authorities.
PDi will help you navigate the regulatory process in order to expedite Canadian marketing approvals.

 


a. Canadian Strategic Planning & Agency Representation
b. Preclinical & Clinical Development
c. Submission Development & Support
d. Post-Approval Consultation